Anoosha Sajjad , Rakia Manzoor , Affaf Sajjad , Muhammad Mohsin , Gamal A. Shazly , Yousef A. Bin Jardan , Rida Fatima , Imran Ibrahim Shaikh
{"title":"Synthesis and characterization of iron oxide-thalidomide nanoconjugates for enhanced anti-inflammatory activities","authors":"Anoosha Sajjad , Rakia Manzoor , Affaf Sajjad , Muhammad Mohsin , Gamal A. Shazly , Yousef A. Bin Jardan , Rida Fatima , Imran Ibrahim Shaikh","doi":"10.1016/j.molstruc.2025.142454","DOIUrl":null,"url":null,"abstract":"<div><div>Thalidomide, recognized for its anti-inflammatory, immunomodulatory, and antiemetic characteristics, is impeded due to its teratogenic effects. This research investigates the synthesis and characterization of iron oxide-thalidomide nanoconjugates (FeO<sub>X</sub>-TH) in order to enhance its pharmacological activity. Iron oxide nanoparticles (FeO<sub>X</sub>-NPs) were synthesized via a coprecipitation method and conjugated with thalidomide, as confirmed by UV–Vis, FTIR, XRD, SEM, and EDS analyses. UV–Vis and FTIR studies demonstrated distinct absorption peaks and molecular vibrations indicative of effective conjugation. XRD and EDS analysis confirmed the structure and composition of the resultant conjugates. Assays for anti-phospholipase A2 (PLA2) activity revealed a notable enhancement in inhibitory potential, with the FT4 conjugate reaching 71 % inhibition, surpassing FT3 at 67 %, FT2 at 44 %, FT1 at 11 %, and NPs free thalidomide at 40 %. The process of nanoconjugation enhanced anti-inflammatory activity in a dose-dependent manner. The findings highlight the potential of FeO<sub>X</sub>-TH conjugates, particularly FT4, as effective agents against inflammatory and oncological disorders. The combination of nanotechnology and pharmacology offers a potential strategy to enhance thalidomide’s effectiveness, though further studies are required to evaluate its safety profile, including potential toxicity concerns.</div></div>","PeriodicalId":16414,"journal":{"name":"Journal of Molecular Structure","volume":"1339 ","pages":"Article 142454"},"PeriodicalIF":4.0000,"publicationDate":"2025-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Molecular Structure","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0022286025011342","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, PHYSICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Thalidomide, recognized for its anti-inflammatory, immunomodulatory, and antiemetic characteristics, is impeded due to its teratogenic effects. This research investigates the synthesis and characterization of iron oxide-thalidomide nanoconjugates (FeOX-TH) in order to enhance its pharmacological activity. Iron oxide nanoparticles (FeOX-NPs) were synthesized via a coprecipitation method and conjugated with thalidomide, as confirmed by UV–Vis, FTIR, XRD, SEM, and EDS analyses. UV–Vis and FTIR studies demonstrated distinct absorption peaks and molecular vibrations indicative of effective conjugation. XRD and EDS analysis confirmed the structure and composition of the resultant conjugates. Assays for anti-phospholipase A2 (PLA2) activity revealed a notable enhancement in inhibitory potential, with the FT4 conjugate reaching 71 % inhibition, surpassing FT3 at 67 %, FT2 at 44 %, FT1 at 11 %, and NPs free thalidomide at 40 %. The process of nanoconjugation enhanced anti-inflammatory activity in a dose-dependent manner. The findings highlight the potential of FeOX-TH conjugates, particularly FT4, as effective agents against inflammatory and oncological disorders. The combination of nanotechnology and pharmacology offers a potential strategy to enhance thalidomide’s effectiveness, though further studies are required to evaluate its safety profile, including potential toxicity concerns.
期刊介绍:
The Journal of Molecular Structure is dedicated to the publication of full-length articles and review papers, providing important new structural information on all types of chemical species including:
• Stable and unstable molecules in all types of environments (vapour, molecular beam, liquid, solution, liquid crystal, solid state, matrix-isolated, surface-absorbed etc.)
• Chemical intermediates
• Molecules in excited states
• Biological molecules
• Polymers.
The methods used may include any combination of spectroscopic and non-spectroscopic techniques, for example:
• Infrared spectroscopy (mid, far, near)
• Raman spectroscopy and non-linear Raman methods (CARS, etc.)
• Electronic absorption spectroscopy
• Optical rotatory dispersion and circular dichroism
• Fluorescence and phosphorescence techniques
• Electron spectroscopies (PES, XPS), EXAFS, etc.
• Microwave spectroscopy
• Electron diffraction
• NMR and ESR spectroscopies
• Mössbauer spectroscopy
• X-ray crystallography
• Charge Density Analyses
• Computational Studies (supplementing experimental methods)
We encourage publications combining theoretical and experimental approaches. The structural insights gained by the studies should be correlated with the properties, activity and/ or reactivity of the molecule under investigation and the relevance of this molecule and its implications should be discussed.